Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Covance lifted by $145m Merck deal

August 4, 2009 Research and Development CRO, Covance

Covance's late-stage development services unit helped the contract research organisation to a 7% increase in second quarter net revenues, ahead …
News

Avastin gets US approval in kidney cancer

August 4, 2009 Research and Development, Sales and Marketing Roche, US, avastin

Roche's rising star Avastin has won US approval to treat the most common type of kidney cancer, the latest in …
News

UCB in ‘dynamic mode’ as work begins at new biologics research centre

July 31, 2009 Research and Development UCB, biologics

 UCB has opened its new biologics research centre in the UK, marking an investment of £25 million for the growing …
Feature

Reshuffle at the top as Mylan deals with quality queries

July 31, 2009 Manufacturing and Production, Research and Development Mylan

US pharmaceutical firm Mylan has promoted chief operating officer Heather Bresch to the post of president as it rides a …
News

Merck Serono asks EMEA to re-think Erbitux rejection

July 30, 2009 Research and Development, Sales and Marketing Cancer, EMEA, Erbitux, Europe, Merck Serono

Merck Serono is to appeal against the European rejection of Erbitux as a lung cancer treatment.Erbitux has been rejected as …
News

Synexus expands

July 30, 2009 Research and Development CRO, Synexus

CRO Synexus has doubled its head office capacity as it continues to grow across the UK, Central and Eastern Europe, …
News

Contract research news in brief

July 28, 2009 Research and Development CRO

The first crop of second-quarter figures from the contract research sector reveals a mixed bag, with PPD and Icon affected …
News

Pharma and diagnostics to converge in personalised medicines

July 28, 2009 Research and Development, Sales and Marketing Diagnostics, strategy

News
Toronto skyline

Canada’s biotech challenge

July 27, 2009 Research and Development Canada, Transition Therapeutics, biotech, funding

 The Niagara Falls are one of the wonders of the natural world, and every year millions of visitors from around …
Feature

Sanofi buys Indian vaccines firm

July 27, 2009 Research and Development, Sales and Marketing Asia, Sanofi-Aventis, vaccines

News

AAIPharma sells development services unit

July 27, 2009 Manufacturing and Production, Research and Development AAI Pharma

US pharmaceutical services firm AAIPharma has sold its drug development division to a private equity firm in another example of …
News

BMS buys Medarex for $2.1 billion

July 24, 2009 Research and Development, Sales and Marketing BMS, MA, Medarex

Bristol-Myers Squibb is to spend $2.1 billion in buying Medarex, the human antibody drug discovery specialists. Princeton-based Medarex is best …
News

Lupus drug shows surprise phase III success

July 23, 2009 Research and Development, Sales and Marketing Benlysta, GSK, HGS, Lupus

 GSK and Human Genome Sciences’ lupus drug Benlysta has surprised analysts by showing unexpectedly positive results in a pivotal late-stage …
News

Effient ‘unlikely’ to takeover from Plavix

July 23, 2009 Research and Development, Sales and Marketing Effient, cv

News

Kennedy calls for overhaul of NICE processes

July 23, 2009 Research and Development, Sales and Marketing NICE, hta

NICE has come under fire over its lack of transparency and its relationship with the industry, following an inquiry by …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026